Iowa Diabetes and Endocrinology Research Center

West Des Moines, Iowa, United States
Diabetes center in West Des Moines, Iowa
1031 Office Park Rd Suite #2, West Des Moines, IA 50265

About Iowa Diabetes and Endocrinology Research Center


"Iowa Diabetes Research's mission is to improve the health and lives of Iowans affected by diabetes. We achieve this by advancing research on diabetes treatment options and by educating patients on how to better manage their diabetes."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials

Clinical Trials at Iowa Diabetes and Endocrinology Research Center


During the past decade, Iowa Diabetes and Endocrinology Research Center conducted 38 clinical trials. In the 10-year time frame, 38 clinical trials started and 15 clinical trials were completed, i.e. on average, 39.5% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 12 clinical trials were completed. i.e. 60% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Safety, Pharmacokinetics, Bioavailability, Food Effect, Drug-Drug Interaction Study of APX001 Administered Orally
2016-10-31
2017-04-20
Completed
46
Absolute BA and OZ439 PK Effect of Different OZ439 Dose Volumes and Cobicistat Co-administration Study
2017-02-28
2017-05-30
Completed
26
A Drug-Drug Interaction Study of CYP3A4 Inhibition and Pan-CYP Induction on APX001
2019-11-12
2020-03-03
Completed
36
Absorption, Elimination and Safety of 14C-labeled Radioactive BTZ-043, a New Compound in TB Treatment
2021-09-21
2021-10-15
Completed
6
Absorption, Distribution, Metabolism and Excretion of BIA 5-1058
2017-03-31
2017-05-24
Completed
15
CG-549 Tablet Pharmacokinetics Study
2019-09-23
2020-06-30
Completed
24

Rows per page:

1–6 of 6

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Iowa Diabetes and Endocrinology Research Center" #1 sponsor was "Eli Lilly and Company" with 18 trials, followed by "Medtronic Diabetes" with 4 trials sponsored, "Boehringer Ingelheim" with 3 trials sponsored, "DexCom, Inc." with 3 trials sponsored and "Gan and Lee Pharmaceuticals, USA" with 3 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 15 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Iowa Diabetes and Endocrinology Research Center" #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "Jaeb Center for Health Research" with 3 trials as a collaborator, "Juvenile Diabetes Research Foundation" with 2 trials as a collaborator, "Medpace, Inc." with 1 trials as a collaborator and "Mylan GmbH" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.
Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Iowa Diabetes and Endocrinology Research Center


According to Clinical.Site data, the most researched conditions in "Iowa Diabetes and Endocrinology Research Center" are "Type 2 Diabetes" (9 trials), "Diabetes Mellitus, Type 2" (7 trials), "Diabetes Mellitus, Type 1" (5 trials), "Type 1 Diabetes" (5 trials) and "Type 1 Diabetes Mellitus" (4 trials). Many other conditions were trialed in "Iowa Diabetes and Endocrinology Research Center" in a lesser frequency.

Clinical Trials Intervention Types at Iowa Diabetes and Endocrinology Research Center


Most popular intervention types in "Iowa Diabetes and Endocrinology Research Center" are "Drug" (29 trials), "Device" (11 trials), "Biological" (3 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (10 trials), "Tirzepatide" (9 trials), "Insulin Degludec" (8 trials), "Dulaglutide" (3 trials) and "Insulin Efsitora Alfa" (3 trials). Other intervention names were less common.

Clinical Trials Genders at Iowa Diabetes and Endocrinology Research Center


The vast majority of trials in "Iowa Diabetes and Endocrinology Research Center" are 43 trials for "All" genders.

Clinical Trials Status at Iowa Diabetes and Endocrinology Research Center


Currently, there are NaN active trials in "Iowa Diabetes and Endocrinology Research Center". undefined are not yet recruiting, 7 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 27 completed trials in Iowa Diabetes and Endocrinology Research Center, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Iowa Diabetes and Endocrinology Research Center, 1 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 8 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status